false
Catalog
The Liver Meeting 2019
Drugs Targeted to Enhance Hepatic Regeneration
Drugs Targeted to Enhance Hepatic Regeneration
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video transcript, various strategies to enhance liver regeneration, particularly in the context of alcoholic hepatitis, are discussed. Impaired liver regeneration due to chronic liver injury, fibrosis, steatosis, and corticosteroid use is highlighted. The potential of regenerative therapies, including bioengineered scaffolds, reprogramming of cells, extracellular vesicles, and cell therapies, is explored. Specific focus is given to drug therapies such as GCSF and interleukin-22, which show promise in improving outcomes in patients with severe alcoholic hepatitis. The use of engineered bacteria producing IL-22 as a potential treatment for alcoholic liver disease is also mentioned. Clinical trials involving uric acid and the combination of anakinra, pentoxifilin, and zinc are discussed, although definitive recommendations for current practice remain limited to steroids for severe cases and supportive care.
Asset Caption
Presenter: Vijay Shah
Keywords
liver regeneration
alcoholic hepatitis
chronic liver injury
regenerative therapies
drug therapies
clinical trials
×
Please select your language
1
English